Celldex Therapeutics has completed a secondary offering that provides the company with financial flexibility.
Todd Campbell, The Motley Fool, The Motley Fool
Wed, 03/04/2015 - 10:59am
Celldex Therapeutics has completed a secondary offering that provides the company with financial flexibility.